A highly effective Administrative Resource is critically important to the successful establishment of an ICMIC. The JHU ICMIC Administrative Resource consists of the Director, the two Associate Directors, a Research Administrator, an Administrative Research Assistant and an Imaging Center Coordinator. This resource will be the administrative center of the JHU ICMIC. The Scientific Advisory Board communicates directly with this resource in terms of monitoring progress, providing evaluations and counseling the Director on issues arising during the administration of the JHU ICMIC. Since the JHU ICMIC consists of approximately 50 or more members spread over 8 departments in the School of Medicine, this resource is essential to maintain the overall infrastructure and day-to-day management of the JHU ICMIC program. Efficient communication and a high level of interaction will be achieved through the Administrative Resource which will include the maintenance of our existing website where postings of information on day-to- day activities will be provided. This resource coordinates the administration of the JHU ICMIC. The Scientific Advisory Board meetings, the Oversight Committee meetings, weekly progress report meetings and the JHU ICMIC Seminar Series will be coordinated and organized through this resource. Monitoring and reconciliation of the various budgets and facilitation of the purchase of supplies are also provided by this resource.

Public Health Relevance

The Administrative Resource is an essential component of the JHU ICMIC, that is required for effective communication, maintaining the overall infrastructure, day-to-day management, and coordination of advisory meetings, retreats, weekly meetings, progress reports and seminars.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA103175-07
Application #
8555370
Study Section
Special Emphasis Panel (ZCA1-SRLB-9 (M1))
Project Start
2003-08-10
Project End
2016-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
7
Fiscal Year
2012
Total Cost
$65,634
Indirect Cost
$23,662
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Winnard Jr, Paul T; Bharti, Santosh K; Penet, Marie-France et al. (2016) Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance. Cancer Res 76:1441-50
Chan, Kannie W Y; Jiang, Lu; Cheng, Menglin et al. (2016) CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response. NMR Biomed 29:806-16
Azad, Babak Behnam; Chatterjee, Samit; Lesniak, Wojciech G et al. (2016) A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts. Oncotarget 7:12344-58
Penet, Marie-France; Chen, Zhihang; Mori, Noriko et al. (2016) Magnetic Resonance Spectroscopy of siRNA-Based Cancer Therapy. Methods Mol Biol 1372:37-47
Xu, Xiang; Yadav, Nirbhay N; Zeng, Haifeng et al. (2016) Magnetization transfer contrast-suppressed imaging of amide proton transfer and relayed nuclear overhauser enhancement chemical exchange saturation transfer effects in the human brain at 7T. Magn Reson Med 75:88-96
Mascini, Nadine E; Cheng, Menglin; Jiang, Lu et al. (2016) Mass Spectrometry Imaging of the Hypoxia Marker Pimonidazole in a Breast Tumor Model. Anal Chem 88:3107-14
Chatterjee, Samit; Lesniak, Wojciech G; Gabrielson, Matthew et al. (2016) A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors. Oncotarget 7:10215-27
Penet, Marie-France; Kakkad, Samata; Pathak, Arvind P et al. (2016) Structure and Function of a Prostate Cancer Dissemination Permissive Extracellular Matrix. Clin Cancer Res :
Lesniak, Wojciech G; Oskolkov, Nikita; Song, Xiaolei et al. (2016) Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform. Nano Lett 16:2248-53
Behnam Azad, Babak; Lisok, Ala; Chatterjee, Samit et al. (2016) Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts. J Nucl Med 57:981-8

Showing the most recent 10 out of 198 publications